Advanced Gene & Cell Technologies (AGCT) , a resident startup of the Skolkovo Foundation’s biomed cluster, has received the first tranche of investment from the RBV Capital venture fund allocated to carry out Russia’s first clinical practice...
The Skolkovo Foundation and its resident startups signed a raft of agreements with major commercial companies during the annual Skolkovo Startup Village on June 6-7. On the first day of the outdoor event for tech entrepreneurs and investors from around the...